Literature DB >> 21633831

High prevalence of upper urinary tract involvement detected by 111indium-oxine leukocyte scintigraphy in patients with candiduria.

J P Horcajada1, M Gutiérrez-Cuadra, I Martínez-Rodríguez, C Salas, J A Parra, N Benito, R Quirce, J M Carril, M C Fariñas.   

Abstract

The purpose of this investigation was to assess the prevalence of upper urinary tract involvement in patients with candiduria by means of (111)indium-oxine-labeled leukocyte scintigraphy. An observational cohort study of patients with confirmed candiduria was conducted in an acute-care teaching hospital in Spain from March 2006 through February 2009. An (111)In-labeled leukocyte scan was performed in order to assess the upper urinary tract involvement. A series of non-matched patients without candiduria nor bacteriuria undergoing scintigraphy to exclude infections in other sites than the urinary tract was also studied. Demographics, baseline illness, and clinical data were recorded. Candiduria was detected in 428 patients, and scintigraphy was performed in 35 of these patients. Twenty-nine patients without candiduria nor bacteriuria were also studied. Positive renal scintigraphy was documented in 24 (68%) patients with confirmed candiduria and in 3 (10%) patients without candiduria (p < 0.005). Renal uptake was not associated with a higher mortality nor with re-admissions. Subclinical pyelonephritis could be more frequent in patients with candiduria than it has been previously considered.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21633831     DOI: 10.1007/s10096-011-1299-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

Review 1.  Multislice CT urography: state of the art.

Authors:  M Noroozian; R H Cohan; E M Caoili; N C Cowan; J H Ellis
Journal:  Br J Radiol       Date:  2004       Impact factor: 3.039

2.  Candiduria.

Authors:  Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2005-09-15       Impact factor: 9.079

Review 3.  Bladder irrigation with amphotericin B and fungal urinary tract infection--systematic review with meta-analysis.

Authors:  Felipe Francisco Tuon; Valdir Sabbaga Amato; Sergio Ricardo Penteado Filho
Journal:  Int J Infect Dis       Date:  2009-01-19       Impact factor: 3.623

4.  The value of a single amphotericin B bladder washout in candiduria.

Authors:  I W Fong
Journal:  J Antimicrob Chemother       Date:  1995-12       Impact factor: 5.790

5.  111Indium labelled leukocyte scintigraphy in the detection of acute prostatitis.

Authors:  J J Mateos; M Velasco; F Lomena; J P Horcajada; F J Setoain; F Martin; M Ortega; D Fuster; C Piera; F Pons; J Mensa
Journal:  Nucl Med Commun       Date:  2002-11       Impact factor: 1.690

Review 6.  The women with dysuria.

Authors:  K Kurowski
Journal:  Am Fam Physician       Date:  1998-05-01       Impact factor: 3.292

Review 7.  Duration of antibacterial treatment for uncomplicated urinary tract infection in women.

Authors:  G Milo; E A Katchman; M Paul; T Christiaens; A Baerheim; L Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 8.  Nosocomial candiduria: a review.

Authors:  T Lundstrom; J Sobel
Journal:  Clin Infect Dis       Date:  2001-04-30       Impact factor: 9.079

Review 9.  Nuclear medicine and infection detection: the relative effectiveness of imaging with 111In-oxine-, 99mTc-HMPAO-, and 99mTc-stannous fluoride colloid-labeled leukocytes and with 67Ga-citrate.

Authors:  Davina K Hughes
Journal:  J Nucl Med Technol       Date:  2003-12

10.  Detection of Candida casts in experimental renal candidiasis: implications for the diagnosis and pathogenesis of upper urinary tract infection.

Authors:  E E Navarro; J S Almario; C King; J Bacher; P A Pizzo; T J Walsh
Journal:  J Med Vet Mycol       Date:  1994-12
View more
  1 in total

1.  Radiolabeling strategies for radionuclide imaging of stem cells.

Authors:  Esther Wolfs; Catherine M Verfaillie; Koen Van Laere; Christophe M Deroose
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.